# MAGNIOM Scientific Policy Specification Conformance Audit Report v2.0

**Specification:** `public/guides/MAGNIOM-Scientific Policy & Algorithm Configuration Specification v2.0.md`  
**Evaluated Sections:** §1–§205 across 13 Verification Clusters  
**Conformance Status:** COMPLIANT (100% Pass)  
**Clusters Passed:** 13 / 13  
**Timestamp:** 2026-09-18T11:56:00.401Z  

---

## 1. Executive Summary

Formal verification of the MAGNIOM scientific policy and algorithm configuration architecture confirms full mathematical, cryptographic, and clinical conformance to Specification v2.0. The policy engine enforces fail-closed positive whitelisting, explicit 4-role cryptographic authorization, boundary parameter checking without silent clamping, and strict indication isolation.

---

## 2. Verification Cluster Audit Results

| Cluster | Focus Area | Sections | Status | Audit Details |
|---|---|---|---|---|
| **1** | Foundational Policy Concepts & Architecture | §1–§17 | ✅ PASS | Domain types formalized; positive whitelisting enforced without transitive inference (§11-13). |
| **2** | Indication Policy Bindings | §18–§33 | ✅ PASS | All 8 indication bindings validated against IndicationPolicyBindingSchema (§18-33). |
| **3** | Target Geometry Policies | §34–§40 | ✅ PASS | 6 geometry types enforced; geometry downcasting prohibited across all indications (§36, §149). |
| **4** | Measurement Capability Policies | §41–§50 | ✅ PASS | Measurement capability requirements, fallback hierarchies, and fusion prohibitions verified (§41-50). |
| **5** | Candidate Generation Policies | §51–§57 | ✅ PASS | Candidate generators bound to evidence paths with pinned SHA-256 package digests (§51-57). |
| **6** | Ranking & Comparison Policies | §58–§64 | ✅ PASS | Cross-domain scalar ranking prohibited; lexicographic/deterministic comparison domains enforced (§58-64). |
| **7** | Clinical Applicability Contexts | §65–§80 | ✅ PASS | Lesion context requirements enforced for neurological indications; disease stages & treatment contexts validated (§65-80). |
| **8** | Target Slate Assembly Policies | §81–§89 | ✅ PASS | Slate capacity limits (max candidates <= 5, primary slots 1-3) and redundancy diversity rules enforced (§81-89). |
| **9** | Parameter Governance & Bounds | §90–§102 | ✅ PASS | All 13 parameters bounded; silent clamping strictly prohibited (§91, §157). |
| **10** | Prohibitions & Anti-Patterns | §103–§109 | ✅ PASS | All 24 global prohibitions enforced, including cross-indication borrowing and unvalidated fusion (§103-109). |
| **11** | Fail-Closed & Fallback Semantics | §110–§116 | ✅ PASS | Fail-closed on unknown tuples; deterministic fallback to evidence baseline with clinician explanation (§110-116). |
| **12** | Lifecycle, Versioning & Signatures | §117–§135 | ✅ PASS | Dual SHA-256 manifests verified, 4-role governance approvals present, Ed25519 signatures validated (§117-135). |
| **13** | Concrete Indication Policies & Verification Framework | §136–§205 | ✅ PASS | 8 indications initialized, 38 failure codes formatted, 9 Golden Cases & 6 Traps verified, impact analysis qualified (§136-205). |

---

## 3. Golden Policy Test Suite Outcomes (§144–§152)

All 9 Golden Policy Test Cases pass with exact expected clinical outcomes:
- **§144 (MDD):** Clinical mode with qualified rs-fMRI selects connectome configuration.
- **§145 (MDD):** FC reliability failure engages evidence-baseline fallback with clinician rationale (§160).
- **§146 (Neuropathic Pain):** Validation mode permits somatotopic generator and verifies hotspot repeatability.
- **§147 (Stroke Motor):** Absent LesionContext triggers hard fail-closed and rejects normal-template fallback.
- **§148 (Stroke Aphasia):** Enforces chronic stage and non-fluent phenotype constraints.
- **§149 (OCD):** Field target requires coil_field geometry and prohibits point-target generators.
- **§150 (TBI):** Attempting cross-indication borrowing of MDD evidence triggers hard security rejection.
- **§151 (PTSD):** Subpopulation constraints preserved without hidden upgrade to broad indication.
- **§152 (Tinnitus):** Requesting Clinical mode for research-only module rejected with `INDICATION_MODULE_NOT_CLINICALLY_PERMITTED`.

---

## 4. Special Policy Traps Verification (§153–§158)

- **§153 Trap 1 (Component Leakage):** Research component referenced in Clinical configuration fails closed.
- **§154 Trap 2 (Evidence Promotion):** Unassigned EvidenceClaim classification cannot establish Clinical authority.
- **§155 Trap 3 (Module Versioning):** Unapproved module version rejected via positive whitelist mismatch.
- **§156 Trap 4 (Plugin Digest):** Altered plugin package SHA-256 digest fails with `TARGET_PLUGIN_INTEGRITY_FAILURE`.
- **§157 Trap 5 (Silent Clamping):** Parameter value outside validated bounds rejected without silent clamping.
- **§158 Trap 6 (Multimodal Fusion):** Coordinate fusion of rs-fMRI + DWI + task fMRI without approved model rejected.

---

## 5. Failure Codes & Clinician Diagnostics (§159–§160)

All 38 Failure Codes (`POL_ERR_001` through `POL_ERR_038`) are bound to standardized clinician-facing message templates, ensuring transparent diagnostic communication without leaking internal stack traces.

---

## 6. Regulatory & Governance Commitments

1. **Hermetic Module Isolation:** No indication module may mutate or inherit rules from another without explicit joint governance qualification (§104).
2. **Dual Manifest Integrity:** Release payload and compatibility configuration are verified via SHA-256 hashes and Ed25519 signatures prior to activation (§126, §127).
3. **Four-Role Authority:** Activation requires affirmative sign-off from Scientific, Clinical, Technical, and Regulatory leads (§121).

---
*Report generated deterministically by `scripts/verification/verify-scientific-policy-spec-conformance.ts`.*
